Respiratory Profile, Region 18, Alaska, Serum
Use
The test is useful for assessing sensitization to various inhalant allergens commonly found in Alaska. It helps define the allergen responsible for eliciting signs and symptoms, identifies allergens responsible for allergic response or anaphylactic episode, confirms sensitization prior to immunotherapy, and investigates the specificity of allergic reactions. The test is not beneficial for patients previously treated with immunotherapy or where management does not depend on allergen specificity.
Special Instructions
For a listing of allergens available for testing, see Allergens - Immunoglobulin E (IgE) Antibodies. If not ordering electronically, complete, print, and send an Allergen Test Request form with the specimen. Collect serum in a serum gel tube, centrifuge, and aliquot into a plastic vial for submission. The test has been cleared or approved by the FDA and is performed at Mayo Clinic Laboratories - Rochester Superior Drive.
Limitations
The test is not useful for determining if residual clinical sensitivity exists after immunotherapy or for cases where medical management does not rely on identifying allergen specificity. A normal total IgE concentration does not rule out allergic disease.
FDA ApprovedNew York Approved
Methodology
Immunoassay (FEIA)
Biomarkers
LOINC Codes
- 51991-8
- 15284-3
- 6020-2
- 6025-1
- 15283-5
- 6833-8
- 53760-5
- 6078-0
- 6090-5
- 6095-4
- 6098-8
- 6096-2
- 19113-0
- 6183-8
- 6212-5
- 6244-8
- 6265-3
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1.3 mL
Minimum Volume
1.1 mL
Container
Plastic vial
Collection Instructions
Centrifuge and aliquot serum into a plastic vial.
Causes for Rejection
Gross hemolysis: OK, Gross lipemia: OK
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 14 days |
| Frozen | 90 days |